Wise John Drayton
SEC CIK 1930805 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED Inc | Chief Commercial Off | 133.0K | — | $3.03M | 22 | 2022-05-23 | 2025-02-06 |
Most active insiders at INSM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Adsett Roger | COO | — | $48.25M |
| 2 | Lewis William | COB, CEO, Dir | — | $32.79M |
| 3 | Flammer Martina M.D. | Chief Medical Off | — | $23.32M |
| 4 | Schaeffer Orlov S Nicole | Chief People Strategy Off | — | $21.11M |
| 5 | LEE LEO | Dir | — | $14.69M |
| 6 | Smith Michael Alexander | CLO | — | $14.00M |
| 7 | SHAROKY MELVIN MD | Dir | — | $4.74M |
| 8 | Brennan David R | Dir | — | $3.10M |
| 9 | ANDERSON ELIZABETH M | Dir | — | $2.98M |
| 10 | Bonstein Sara | CFO | — | $2.13M |
Wise John Drayton made no open-market trades at INSM in the last 12 months.
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-07 | 2025-02-06+ | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $80.90 | -7,920 | 133.0K | -6% | -$640.7K |
| 2025-02-07 | 2025-02-05 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | $0.00 | +15.4K | 140.9K | +12% | $0 | |
| D | 2025-01-10 | 2025-01-07 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | M - OptEx | $16.07 | +10.0K | 132.5K | +8% | +$160.7K |
| DM | 2025-01-10 | 2025-01-07+ | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $65.95 | -13.6K | 119.6K | -10% | -$896.1K |
| D | 2025-01-10 | 2025-01-08 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | — | +6,657 | 125.8K | +6% | — |
| DM | 2024-05-30 | 2024-05-28 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $49.79 | -7,852 | 121.7K | -6% | -$390.9K |
| D | 2024-05-30 | 2024-05-28 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | M - OptEx | $12.58 | +6,250 | 127.9K | +5% | +$78.6K |
| D | 2024-05-15 | 2024-05-14 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $25.47 | -5,088 | 123.3K | -4% | -$129.6K |
| D | 2024-05-15 | 2024-05-13 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | — | +14.5K | 128.3K | +13% | — |
| 2024-01-11 | 2024-01-09 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $28.78 | -1,861 | 113.8K | -2% | -$53.6K | |
| DM | 2024-01-05 | 2024-01-03+ | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $29.20 | -21.2K | 115.7K | -16% | -$620.1K |
| D | 2024-01-05 | 2024-01-04 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | — | +12.9K | 116.9K | +12% | — |
| D | 2024-01-05 | 2024-01-03 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | M - OptEx | $19.11 | +20.1K | 124.1K | +19% | +$383.6K |
| 2023-05-26 | 2023-05-25 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $18.95 | -3,366 | 102.7K | -3% | -$63.8K | |
| M | 2023-05-17 | 2023-05-15+ | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $18.44 | -2,887 | 106.0K | -3% | -$53.2K |
| D | 2023-05-15 | 2023-05-11 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | — | +31.7K | 108.9K | +41% | — |
| 2023-01-12 | 2023-01-10 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $17.96 | -779 | 77.3K | -1.0% | -$14.0K | |
| D | 2023-01-06 | 2023-01-05 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $19.74 | -1,160 | 70.5K | -2% | -$22.9K |
| D | 2023-01-06 | 2023-01-05 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | — | +7,598 | 78.1K | +11% | — |
| 2022-11-22 | 2022-11-22 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $18.84 | -7,154 | 71.6K | -9% | -$134.8K | |
| 2022-08-12 | 2022-08-10 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | S - Sale | $27.79 | -258 | 78.8K | -0.3% | -$7,170 | |
| D | 2022-05-25 | 2022-05-23 | INSM | INSMED Inc | Wise John Drayton | Chief Commercial Off | A - Grant | — | +26.2K | 78.1K | +51% | — |
Purchase Sale Sale after option exercise All abbreviations